Disclosure Of Intangible Assets [Text Block]

Heidelberg Pharma AG - Filing #6821989

Concept 2020-12-01 to
2021-11-30
As at
2021-11-30
As at
2020-11-30
2019-12-01 to
2020-11-30
Disclosure of intangible assets [text block]
Disclosure of detailed information about intangible assets [text block]
Disclosure of detailed information about intangible assets [abstract]
Disclosure of detailed information about intangible assets [line items]
Reconciliation of changes in intangible assets other than goodwill [abstract]
Intangible assets other than goodwill
2.900.256 EUR
2.818.316 EUR
Research and development expense
18.750.257 EUR
18.286.980 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.